APAF1 |
apoptotic peptidase-activating factor 1 |
AR-V7 |
androgen receptor variant 7 |
CAFs |
cancer-associated fibroblast |
CRPC |
castrate-resistant prostate cancer |
CTCs |
circulating tumor cells |
EGFR |
epidermal growth factor receptor |
EMT |
epithelial–mesenchymal transition |
EV |
extracellular vesicles |
FASL |
ligand Fas |
HIF-1α |
hypoxia-inducible factor 1α |
HSP |
heat shock proteins |
ITGB4 |
integrin β4 |
MICs |
metastases-initiating cells |
miR |
micro RNA |
MMP |
matrix metalloproteinase |
MVBs |
multivesicular bodies |
PCa |
prostate cancer |
PDCD4 |
programmed cell death 4 |
PDL-1 |
programmed death ligand 1 |
PSA |
prostate specific antigen |
RANKL |
receptor activator for nuclear factor κB ligand |
RSU1 |
Ras suppressor protein 1 |
siRNA |
small interfering RNA |
STAG2 |
cohesin subunit SA-2 |
TDSFs |
tumor-derived secreted factors |
TGFβ |
transforming growth factor β |
VCL |
vinculin |